Bolt Biotherapeutics, Inc. (BOLT)
6.27
+2.08
(+49.64%)
USD |
NASDAQ |
Oct 23, 16:00
6.85
+0.58
(+9.25%)
After-Hours: 20:00
Bolt Biotherapeutics EPS Diluted (Quarterly) : -4.567 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.567 |
| March 31, 2026 | -4.311 |
| December 31, 2025 | -3.839 |
| September 30, 2025 | -3.722 |
| June 30, 2025 | -4.464 |
| March 31, 2025 | -0.288 |
| December 31, 2024 | -8.325 |
| September 30, 2024 | -0.3968 |
| June 30, 2024 | -0.5559 |
| March 31, 2024 | -0.284 |
| December 31, 2023 | -0.4719 |
| September 30, 2023 | -0.4293 |
| June 30, 2023 | -0.4783 |
| March 31, 2023 | -0.4506 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.5325 |
| September 30, 2022 | -0.581 |
| June 30, 2022 | -0.6077 |
| March 31, 2022 | -0.6377 |
| December 31, 2021 | -0.7261 |
| September 30, 2021 | -0.6281 |
| June 30, 2021 | -0.6342 |
| March 31, 2021 | -1.138 |
| December 31, 2020 | -0.8562 |
| September 30, 2020 | -0.2759 |
| June 30, 2020 | -0.3151 |
| March 31, 2020 | -0.2382 |
| December 31, 2019 | -0.2668 |
| September 30, 2019 | -0.2047 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.72M |
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 7.725M |
| Enterprise Value | 15.90M |
| Gross Profit Margin (Quarterly) | -3.32K% |
| Profit Margin (Quarterly) | -154.4K% |
| Earnings Yield | -262.2% |
| Normalized Earnings Yield | -247.27 |